Contingency management for the treatment of methamphetamine use disorders

John M. Roll, Nancy M. Retry, Maxine L. Stitzer, Mary L. Brecht, Jessica Peirce, Michael J. McCann, Jack Blaine, Marilyn MacDonald, Joan DiMaria, Leroy Lucero, Scott Kellogg

Research output: Contribution to journalArticlepeer-review

111 Scopus citations

Abstract

Objective: Theory and some preliminary evidence suggest that contingency management may be an effective treatment strategy or adjunct to psychosocial treatment for methamphetamine use disorders. An experimentally rigorous investigation on the topic was provided by a large multisite trial conducted under the auspices of the Clinical Trials Network of the National Institute on Drug Abuse. Method: The authors report data on 113 participants who were diagnosed with methamphetamine abuse or dependence. They were randomly assigned to receive 12 weeks of either treatment as usual or treatment as usual plus contingency management. Urine samples were tested for illicit drugs, and breath samples were tested for alcohol. The reinforcers for drug-negative samples were plastic chips, some of which could be exchanged for prizes. The number of plastic chips drawn increased with each week of negative samples but was reset to one after a missed or positive sample. Results: The participants in both groups remained in treatment for equivalent times, but those receiving contingency management in addition to usual treatment submitted significantly more negative samples, and they were abstinent for a longer period of time (5 versus 3 weeks). Conclusions: These results suggest that contingency management has promise as component in treatment strategies for methamphetamine use disorder.

Original languageEnglish (US)
Pages (from-to)1993-1999
Number of pages7
JournalAmerican Journal of Psychiatry
Volume163
Issue number11
DOIs
StatePublished - Nov 2006

ASJC Scopus subject areas

  • Psychiatry and Mental health

Fingerprint

Dive into the research topics of 'Contingency management for the treatment of methamphetamine use disorders'. Together they form a unique fingerprint.

Cite this